Chiara Masucci
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.
Journal: Annals of hematology
Published: April 18, 2025
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
Journal: European journal of haematology
Published: July 23, 2024
Fostamatinib combined with TPO-RAs or steroids as a bridge to monotherapy or as time-limited continuous treatment in relapsed chronic ITP: A single-centre case series.
Journal: British journal of haematology
Published: December 04, 2023
Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up.
Journal: Mediterranean journal of hematology and infectious diseases
Published: November 21, 2023
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort.
Journal: European journal of haematology
Published: October 03, 2023
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases.
Journal: Leukemia & lymphoma
Published: July 12, 2023
One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission.
Journal: European journal of haematology
Published: July 08, 2023
Systemic mastocytosis: 2023 update on diagnosis and management in adults.
Journal: Expert opinion on emerging drugs
Published: May 31, 2023
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination.
Journal: Frontiers in oncology
Published: April 26, 2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS.
Journal: Frontiers in oncology
Published: February 21, 2023
Case Report: Infectious prophylaxis in hematological malignancies.
Journal: Frontiers in oncology
Published: February 10, 2023
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report.
Journal: Mediterranean journal of hematology and infectious diseases
Published: March 20, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026